Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
Completed · Phase 3
Conditions studied: Myocardial Ischemia
In brief
A magnetocardiograph (MCG) is a medical device capable of recording the magnetic fields that arise from the electrical activity of the heart. It was developed for the general purpose as a noninvasive, non-contact diagnostic tool of obstructive coronary artery disease (CAD), and especially of cardiac ischemia. The overall objective of the present study is to demonstrate the efficacy of this MCG device in the diagnosis of lack of oxygen to an area of the heart (as in an Heart attack) in patients presenting with chest pain.
Key facts
- Study ID
- NCT00170027
- Run by
- Mayo Clinic
- People needed
- 250
- Starts
- 2003-07-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2011-02-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.